p63 Attenuates Epithelial to Mesenchymal Potential in an Experimental Prostate Cell Model

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Olsen, Jan Roger ^a   Oyan, Anne Margrete ^a,b   Rostad, Kari ^a   Hellem, Margrete R ^a   Liu, Jie ^c   Li, Lisha ^c   Micklem, David R ^d   Haugen, Hallvard ^a,d   Lorens, James B ^a,d   Rotter, Varda ^e   Ke, Xi Song ^a,b   Lin, Biaoyang ^c,f,g   Kalland, Karl Henning ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c ZHEJIANG UNIVERSITY   (China)

^d BerGenBio   (Norway)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^f SWEDISH MEDICAL CENTER   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; ISOCITRATE DEHYDROGENASE 1; PROTEIN P63; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN;

ARTICLE; ATTENUATION; BINDING SITE; CELL ADHESION; CELL JUNCTION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC TRAIT; HUMAN; HUMAN CELL; MALE; MESENCHYME; PHENOTYPE; PLASTICITY; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CADHERINS; CELL LINE; CELL SHAPE; CONSENSUS SEQUENCE; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE ONTOLOGY; HOMEODOMAIN PROTEINS; HUMANS; INTERCELLULAR JUNCTIONS; LAMININ; MALE; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROSTATE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84877056160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062547     Document Type: Article

References (40)

1. Deyoung MP, Ellisen LW, (2007) p63 and p73 in human cancer: defining the network. Oncogene 26: 5169-5183.
2. Mangiulli M, Valletti A, Caratozzolo MF, Tullo A, Sbisa E, et al. (2009) Identification and functional characterization of two new transcriptional variants of the human p63 gene. Nucleic Acids Res 37: 6092-6104.
3. Grisanzio C, Signoretti S, (2008) p63 in prostate biology and pathology. J Cell Biochem 103: 1354-1368.
4. Signoretti S, Pires MM, Lindauer M, Horner JW, Grisanzio C, et al. (2005) p63 regulates commitment to the prostate cell lineage. Proc Natl Acad Sci U S A 102: 11355-11360.
5. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON, (2010) Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
6. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, et al. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461: 495-500.
7. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
8. Ke XS, Qu Y, Goldfinger N, Rostad K, Hovland R, et al. (2008) Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation. PLoS ONE 3: e3368.
9. Ke XS, Li WC, Hovland R, Qu Y, Liu RH, et al. (2011) Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Exp Cell Res 317: 234-247.
10. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107: 15449-15454.
11. Craene BD, Berx G, (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13: 97-110.
12. Lindsay J, McDade SS, Pickard A, McCloskey KD, McCance DJ, (2011) Role of DeltaNp63gamma in epithelial to mesenchymal transition. J Biol Chem 286: 3915-3924.
13. Parsons JK, Saria EA, Nakayama M, Vessella RL, Sawyers CL, et al. (2009) Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells. Prostate 69: 559-569.
14. Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, et al. (2006) p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 8: 551-561.
15. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464-468.
16. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
17. Jothi R, Cuddapah S, Barski A, Cui K, Zhao K, (2008) Genome-wide identification of in vivo protein-DNA binding sites from ChIP-Seq data. Nucleic Acids Res 36: 5221-5231.
18. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
19. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137.
20. Ji H, Jiang H, Ma W, Johnson DS, Myers RM, et al. (2008) An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat Biotechnol 26: 1293-1300.
21. McDade SS, Henry AE, Pivato GP, Kozarewa I, Mitsopoulos C, et al. (2012) Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation. Nucleic Acids Res 40: 7190-7206.
22. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
23. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
24. Kouwenhoven EN, van Heeringen SJ, Tena JJ, Oti M, Dutilh BE, et al. (2010) Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet 6: e1001065.
25. Li Q, Mattingly RR, (2008) Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells. Neoplasia 10: 1444-1458.
26. Hill L, Browne G, Tulchinsky E (2012) ZEB/miR-200 feedback loop: At the crossroads of signal transduction in cancer. Int J Cancer.
27. Valastyan S, Weinberg RA, (2011) Roles for microRNAs in the regulation of cell adhesion molecules. J Cell Sci 124: 999-1006.
28. Gandellini P, Profumo V, Casamichele A, Fenderico N, Borrelli S, et al. (2012) miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ.
29. Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, et al. (2012) Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci U S A 109: 15312-15317.
30. Wiklund ED, Bramsen JB, Hulf T, Dyrskjot L, Ramanathan R, et al. (2011) Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 128: 1327-1334.
31. Ke XS, Qu Y, Cheng Y, Li WC, Rotter V, et al. (2010) Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics 11: 669.
32. Thepot A, Hautefeuille A, Cros MP, Abedi-Ardekani B, Petre A, et al. (2010) Intraepithelial p63-dependent expression of distinct components of cell adhesion complexes in normal esophageal mucosa and squamous cell carcinoma. Int J Cancer 127: 2051-2062.
33. Polo JM, Anderssen E, Walsh RM, Schwarz BA, Nefzger CM, et al. (2012) A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151: 1617-1632.
34. Buganim Y, Faddah DA, Cheng AW, Itskovich E, Markoulaki S, et al. (2012) Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150: 1209-1222.
35. Coppola V, Musumeci M, Patrizii M, Cannistraci A, Addario A, et al. (2012) BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition. Oncogene.
36. Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, et al. (2006) hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis. Cancer Res 66: 3531-3540.
37. Petersen K, Oyan AM, Rostad K, Olsen S, Bo TH, et al. (2007) Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization. Anal Biochem 366: 46-58.
38. Ke XS, Qu Y, Rostad K, Li WC, Lin B, et al. (2009) Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS ONE 4: e4687.
39. Dysvik B, Jonassen I, (2001) J-Express: exploring gene expression data using Java. Bioinformatics 17: 369-370.
40. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.